Form 4: Hims & Hers Health CEO Andrew Dudum Reports Stock Transactions
SEC Form 4
Andrew Dudum, CEO of Hims & Hers Health, reports the vesting and tax withholding of restricted stock units, resulting in changes to his beneficial ownership.
Summary
- On September 13, 2024, Andrew Dudum, the CEO of Hims & Hers Health, Inc., reported transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
- 176,308 shares of Class A Common Stock were acquired through the vesting of RSUs.
- 97,028 shares of Class A Common Stock were disposed of to cover tax withholding obligations related to the RSU vesting at a price of $16.57.
- Various RSUs were vested, including 35,447, 35,242, 7,330, 106, 3,575, 1,789, 18,289, and 74,530 units.
- These RSUs vest over a 4-year period in substantially equal quarterly installments on specified vesting dates.
- Following these transactions, Dudum's direct and indirect beneficial ownership of Class A Common Stock and RSUs has been updated.
Sentiment
Score: 6
Explanation: The document is neutral in tone, simply reporting required information about stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Positives
- The vesting of RSUs indicates that performance milestones or time-based service requirements have been met.
- The transactions reflect Dudum's continued stake in the company through direct and indirect ownership.
Negatives
- The disposal of shares to cover tax obligations reduces Dudum's direct holdings, although this is a common practice.
Risks
- The value of the shares could fluctuate, impacting the overall value of Dudum's holdings.
- Future vesting schedules and tax implications could lead to further transactions.
Future Outlook
The document does not contain specific forward-looking statements, but it implies continued vesting of RSUs over time.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's confidence and compensation structures.
Comparison to Industry Standards
- Executive compensation packages often include RSUs that vest over several years to align management's interests with long-term shareholder value.
- Tax withholding practices related to RSU vesting are standard across the industry.
- Companies like Teladoc Health and GoodRx, which operate in similar telehealth spaces, also utilize RSU grants as part of their executive compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
- The vesting of RSUs incentivizes the CEO to continue driving company performance.
Key Dates
| Date | Description |
|---|---|
| 10/15/1997 | Date of Richard M. Dudum Irrevocable 1 U/A |
| July 2, 2015 | Date of Andrew Dudum 2015 Trust |
| 8/10/2021 | Date of Dudum Family Heritage Trust UAD |
| 11/1/2021 | Date of AD 2021 GRAT |
| 9/7/2022 | Date of AD 2022 GRAT 2 |
| 11/28/2022 | Date of AD 2022 GRAT 3 |
| 6/15/2023 | First Company Quarterly Vesting Date for some RSUs |
| 9/5/2023 | Date of AD 2023 GRAT |
| 09/13/2024 | Date of reported transactions (vesting and disposal of shares) |
| 09/17/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.